Pneumococcal

The Pharmacy Times® Pneumococcal Resource Center is a comprehensive resource for clinical news and expert insights for any infection caused by the bacteria Streptococcus pneumoniae, or pneumococcus.

Latest News

Pneumococcal vaccine | Image Credit: Iryna - stock.adobe.com
FDA Approves V116 for Prevention of Invasive Pneumococcal Disease and Pneumonia

June 18th 2024

V116 (Capvaxive; Merck) elicited higher immune responses than the comparator for the serotypes that are unique to the vaccine, according to studies submitted to the FDA.

PNEUMOCOCCAL VACCINE text is written on a vial | Image Credit: Iryna - stock.adobe.com
Study: Larger Lifetime Cost Savings for V116 Compared With PCV20

June 8th 2024

PNEUMOCOCCAL VACCINE text is written on a vial whose ampoule is held by a hand in a medical disposable glove. | Image Credit: Iryna - stock.adobe.com
Quality Improvement Methodology Increases Pneumococcal Vaccination for Patients With Rheumatic Diseases

May 31st 2024

Pneumococcal pneumonia, bacteria Streptococcus pneumoniae in human lungs | Image Credit: Dr_Microbe - stock.adobe.com
Study: Contact With Children Causes Transmission of Pneumococcal Disease Among Older Adults

May 15th 2024

Study: 3 Doses of PCV13 Prevents Vaccine-Type Invasive Pneumococcal Disease in Children
Study: 3 Doses of PCV13 Prevents Vaccine-Type Invasive Pneumococcal Disease in Children

May 8th 2024

Video Interviews

More News

© 2024 MJH Life Sciences

All rights reserved.